291 related articles for article (PubMed ID: 5081450)
1. [Treatment of spastic bronchitis with a new bronchospasmolytic agent].
Heller K
Wien Med Wochenschr; 1972 Oct; 122(42):606-9. PubMed ID: 5081450
[No Abstract] [Full Text] [Related]
2. [Bronchospasmolytic and extrabronchial action of Berotec (Fenoterol, Th 1165) in patients with asthma or chronic bronchitis with bronchial spasm].
Rozniecki J; Grabski W
Pol Tyg Lek; 1975 Feb; 30(7):301-4. PubMed ID: 1118349
[No Abstract] [Full Text] [Related]
3. [Clinical experiences with a new bronchospasmolytic agent in infancy and childhood].
Nachtigall C
Med Monatsschr; 1968 Dec; 22(12):555-7. PubMed ID: 5709425
[No Abstract] [Full Text] [Related]
4. Metaproterenol, a new bronchodilator:: comparison with isoproterenol.
Pelz HH
Am J Med Sci; 1967 Mar; 253(3):321-4. PubMed ID: 6021691
[No Abstract] [Full Text] [Related]
5. [Clinical experiences with a new beta 2-receptor stimulant in spastic lung diseases in pediatrics].
Starnegg Q
Wien Med Wochenschr; 1971 May; 121(22):455-7. PubMed ID: 5092121
[No Abstract] [Full Text] [Related]
6. Is there a selective indication for a parasympatholytic (Atrovent) and for a beta-sympathomimetic (Berotec) in asthma and asthmatic bronchitis?
Verstraeten JM
Acta Tuberc Pneumol Belg; 1976; 67(3-4):130-55. PubMed ID: 138352
[No Abstract] [Full Text] [Related]
7. [Spasmolytic and mucolytic agents in the treatment of acute dyspneic pneumopathies in children].
Manicatide ET; Căpraru H
Pediatria (Bucur); 1973; 22(4):357-60. PubMed ID: 4761443
[No Abstract] [Full Text] [Related]
8. Anticholinergic and beta-sympathomimetic inhalation challenges in asthma and bronchitis.
Marcq M; Minette A
Acta Tuberc Pneumol Belg; 1976; 67(3-4):156-62. PubMed ID: 1016524
[No Abstract] [Full Text] [Related]
9. [Effects of sch 1000 metered dose aerosol, in patients with bronchial asthma and chronic bronchitis (author's transl)].
Yernault JC; Dejonghe M; Denaut M; Englert M; de Coster A
Acta Tuberc Pneumol Belg; 1975; 66(4-5):421-8. PubMed ID: 131479
[No Abstract] [Full Text] [Related]
10. [On the treatment of spastic bronchitis in infants and children using a new bronchospasmolytic agent].
Ertogan F; Stolting G; Russ D
Dtsch Med J; 1969 Jun; 20(12):413-5. PubMed ID: 5801770
[No Abstract] [Full Text] [Related]
11. [Evaluation of the bronchospasmolytic activity of alupent and ipradol].
Makel'skiĭ VV; Iartsev SS
Sov Med; 1974 Sep; 0(9):142-3. PubMed ID: 4409508
[No Abstract] [Full Text] [Related]
12. [Asthmalitan Depot-tablets].
Ther Ggw; 1973 Nov; 112(11):1816 passim. PubMed ID: 4778533
[No Abstract] [Full Text] [Related]
13. [Results of a clinical trial of a newly developped bronchospasmolytic agent (hexoprenalin, Ipradol)].
Witek F
Wien Klin Wochenschr; 1971 Feb; 83(7):114-7. PubMed ID: 5278390
[No Abstract] [Full Text] [Related]
14. [Comparison of the bronchodilator action of salbutamol and orciprenaline by aerosol administration in patients with chronic bronchopneumopathy].
Sorbini CA; Todisco T; Boschetti E
Minerva Med; 1976 Mar; 67(16):1079-83. PubMed ID: 1264384
[No Abstract] [Full Text] [Related]
15. [Clinical evaluation of the effectiveness of aminophylline in treating bronchial asthma and spastic bronchitis].
Chyrek-Borowska S; Szymański W; Niklińska B; Obrzut D; Michalska I
Pol Tyg Lek; 1988 Oct 17-24; 43(42-43):1377-9. PubMed ID: 3075278
[No Abstract] [Full Text] [Related]
16. [A new bronchospasmolytic].
Brunner R
Arzneimittelforschung; 1972 Jul; 22(7):1223-5. PubMed ID: 4678135
[No Abstract] [Full Text] [Related]
17. [Anticholinergic agents as bronchodilator agents. Significance of acetylcholine as a bronchoconstrictor transmitter agent in airway obstruction].
Ulmer WT; Dorsch J; Iravani J; Schüler KG; Stempel G; Vastag E
Arzneimittelforschung; 1973 Mar; 23(3):468-76. PubMed ID: 4740138
[No Abstract] [Full Text] [Related]
18. [Etimizol in the treatment of chronic bronchitis complicated by bronchial spasm, and bronchial asthma].
Andriushchenko OM; Krasnova LI
Klin Med (Mosk); 1982 Nov; 60(11):43-6. PubMed ID: 7154629
[No Abstract] [Full Text] [Related]
19. [Action of the new domestic ganglionic-blocking agent "Cypenam" on bronchial patency in acute studies].
Simonian AT; Melik-Adamian AA; Topchian AA
Zh Eksp Klin Med; 1967; 7(3):19-23. PubMed ID: 5620034
[No Abstract] [Full Text] [Related]
20. Bronchodilators.
Cochrane GM
Practitioner; 1979 Oct; 223(1336):489-98. PubMed ID: 523401
[No Abstract] [Full Text] [Related]
[Next] [New Search]
